Table 3 Regular prescription drugs change between baseline and the 1-year follow up
| Â | Number of participants, n (%) | |||
|---|---|---|---|---|
| Â | Intervention group | Control group | ||
|  | n = 22 | n = 18 | ||
Antihypertensive drugs | Â | Â | Â | Â |
Increase | 1 | (5) | 5 | (28) |
Stable | 21 | (95) | 13 | (72) |
Decrease | 0 | Â | 0 | Â |
Lipid-lowering drug | Â | Â | Â | Â |
Increase | 3 | (14) | 1 | (6) |
Stable | 19 | (86) | 17 | (94) |
Decrease | 0 | Â | 0 | Â |
Anti-diabetic | Â | Â | Â | Â |
Increase | 0 | Â | 1 | (6) |
Stable | 22 | (100) | 16 | (88) |
Decrease | 0 | Â | 1 | (6) |